Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Immunoglobulin A vasculitis (IgA-V), formerly called Henoch-Schönlein purpura, is an immune vasculitis. Relapses are frequent (30%) and most of the time cutaneous (90%). Cutaneous involvement in adults is more severe (haemorrhagic blister or necrotic skin lesions) and more extensive than in children. Quality of life can be significantly altered by frequent cutaneous relapses. Colchicine, historically used for gout flares, is known to be an " old " low cost drug inducing very few adverse events. This molecule inhibits polymorphonuclear cell-chemotaxis to the site of inflammation explaining colchicine clinical efficacy in diseases such as Familial Mediterranean Fever or Behçet disease. Efficacy of colchicine has also been reported in cutaneous leukocytoclastic vasculitis including IgA-V, but without clinical studies supporting this attitude.
Official title: Evaluation of Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
27
Start Date
2019-11-12
Completion Date
2022-01-12
Last Updated
2026-11-06
Healthy Volunteers
No
Conditions
Interventions
Colchicine
colchicine 1mg/day
Locations (1)
Saint Louis Hospital
Paris, France